View in EDS

PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.

Saved in:
Bibliographic Details
Title: PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.
Authors: Heimbach T; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States., Musuamba Tshinanu F; Belgian Federal Agency for Medicines and Health Products, Galileelaan 5/03, Brussels 1210, Belgium., Raines K; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Borges L; ANVISA, SIA Trecho 5 - Guará, Brasília, DF 71205-050, Brazil., Kijima S; Office of New Drug V, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo 100-0013, Japan., Malamatari M; Medicines & Healthcare Products Regulatory Agency, 10 S Colonnade, London SW1W 9SZ, U.K., Moody R; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Veerasingham S; Pharmaceutical Drugs Directorate (PDD), Health Canada, 1600 Scott St, Ottawa, Ontario K1A 0K9, Canada., Seo P; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Turner D; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Fang L; Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Stillhart C; Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Basel CH-4070, Switzerland., Bransford P; Data and Computational Sciences, Vertex Pharmaceuticals, Inc., Boston, Massachusetts 02210, United States., Ren X; PK Sciences/Translational Medicine, BioMedical Research, Novartis, One Health Plaza, East Hanover, New Jersey 07936, United States., Patel N; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Sperry D; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States., Chen H; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Rostami-Hodjegan A; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.; Centre for Applied Pharmacokinetic Research, University of Manchester, Stopford Building, Oxford Road, Manchester M139PT, U.K., Lukacova V; Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534, United States., Sun D; The University of Michigan, North Campus Research Complex (NCRC), 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States., Nguefack JF; Head of Biopharmacy Team, Montpellier, Synthetics Platform, Global CMC, Sanofi, Paris 75008, France., Carducci T; Analytical Commercialization Technology, Merck & Co., Inc., 126 E. Lincoln Ave, Rahway, New Jersey 07065, United States., Grimstein M; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Pepin X; Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534, United States., Jamei M; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Stamatopoulos K; Biopharmaceutics, DPD, MDS, GlaxoSmithKline, David Jack Centre, Park Road, Ware SG12 0DP, U.K., Li M; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Sanghavi M; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Tannergren C; Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 43183, Sweden., Mandula H; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Zhao Z; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States., Ju TR; Analytical R&D, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States., Wagner C; Global Drug Product Development, Global CMC Development, the Healthcare Business of Merck KGaA, Darmstadt 64293, Germany., Arora S; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium., Wang M; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States., Rullo G; Regulatory CMC, AstraZeneca, 1 Medimmune Way, Gaithersburg, Maryland 20878, United States., Mitra A; Clinical Pharmacology, Kura Oncology Inc, Boston, Massachusetts 02210, United States., Kollipara S; Biopharmaceutics Group, Global Clinical Management, Integrated Product Development Organization (IPDO), Dr. Reddy's Laboratories Ltd., Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090 Telangana, India., Chirumamilla SK; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom., Polli JE; School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States., Mackie C; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
Source: Molecular pharmaceutics [Mol Pharm] 2024 Nov 04; Vol. 21 (11), pp. 5353-5372. Date of Electronic Publication: 2024 Sep 30.
Publication Type: Journal Article; Review; Research Support, U.S. Gov't, P.H.S.
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39348508
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Heimbach+T%22">Heimbach T</searchLink>; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States.<br /><searchLink fieldCode="AU" term="%22Musuamba+Tshinanu+F%22">Musuamba Tshinanu F</searchLink>; Belgian Federal Agency for Medicines and Health Products, Galileelaan 5/03, Brussels 1210, Belgium.<br /><searchLink fieldCode="AU" term="%22Raines+K%22">Raines K</searchLink>; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Borges+L%22">Borges L</searchLink>; ANVISA, SIA Trecho 5 - Guará, Brasília, DF 71205-050, Brazil.<br /><searchLink fieldCode="AU" term="%22Kijima+S%22">Kijima S</searchLink>; Office of New Drug V, Pharmaceuticals and Medical Devices Agency (PMDA), Tokyo 100-0013, Japan.<br /><searchLink fieldCode="AU" term="%22Malamatari+M%22">Malamatari M</searchLink>; Medicines & Healthcare Products Regulatory Agency, 10 S Colonnade, London SW1W 9SZ, U.K.<br /><searchLink fieldCode="AU" term="%22Moody+R%22">Moody R</searchLink>; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Veerasingham+S%22">Veerasingham S</searchLink>; Pharmaceutical Drugs Directorate (PDD), Health Canada, 1600 Scott St, Ottawa, Ontario K1A 0K9, Canada.<br /><searchLink fieldCode="AU" term="%22Seo+P%22">Seo P</searchLink>; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Turner+D%22">Turner D</searchLink>; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fang+L%22">Fang L</searchLink>; Division of Quantitative Methods and Modeling (DQMM), Office of Research and Standards (ORS), Office of Generic Drugs (OGD), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Stillhart+C%22">Stillhart C</searchLink>; Pharmaceutical R&D, F. Hoffmann-La Roche Ltd., Basel CH-4070, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bransford+P%22">Bransford P</searchLink>; Data and Computational Sciences, Vertex Pharmaceuticals, Inc., Boston, Massachusetts 02210, United States.<br /><searchLink fieldCode="AU" term="%22Ren+X%22">Ren X</searchLink>; PK Sciences/Translational Medicine, BioMedical Research, Novartis, One Health Plaza, East Hanover, New Jersey 07936, United States.<br /><searchLink fieldCode="AU" term="%22Patel+N%22">Patel N</searchLink>; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Sperry+D%22">Sperry D</searchLink>; Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States.<br /><searchLink fieldCode="AU" term="%22Chen+H%22">Chen H</searchLink>; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Rostami-Hodjegan+A%22">Rostami-Hodjegan A</searchLink>; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.; Centre for Applied Pharmacokinetic Research, University of Manchester, Stopford Building, Oxford Road, Manchester M139PT, U.K.<br /><searchLink fieldCode="AU" term="%22Lukacova+V%22">Lukacova V</searchLink>; Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534, United States.<br /><searchLink fieldCode="AU" term="%22Sun+D%22">Sun D</searchLink>; The University of Michigan, North Campus Research Complex (NCRC), 1600 Huron Parkway, Ann Arbor, Michigan 48109, United States.<br /><searchLink fieldCode="AU" term="%22Nguefack+JF%22">Nguefack JF</searchLink>; Head of Biopharmacy Team, Montpellier, Synthetics Platform, Global CMC, Sanofi, Paris 75008, France.<br /><searchLink fieldCode="AU" term="%22Carducci+T%22">Carducci T</searchLink>; Analytical Commercialization Technology, Merck & Co., Inc., 126 E. Lincoln Ave, Rahway, New Jersey 07065, United States.<br /><searchLink fieldCode="AU" term="%22Grimstein+M%22">Grimstein M</searchLink>; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Pepin+X%22">Pepin X</searchLink>; Simulations Plus Inc., 42505 10th Street West, Lancaster, California 93534, United States.<br /><searchLink fieldCode="AU" term="%22Jamei+M%22">Jamei M</searchLink>; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Stamatopoulos+K%22">Stamatopoulos K</searchLink>; Biopharmaceutics, DPD, MDS, GlaxoSmithKline, David Jack Centre, Park Road, Ware SG12 0DP, U.K.<br /><searchLink fieldCode="AU" term="%22Li+M%22">Li M</searchLink>; Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Sanghavi+M%22">Sanghavi M</searchLink>; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Tannergren+C%22">Tannergren C</searchLink>; Biopharmaceutics Science, New Modalities & Parenteral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Gothenburg 43183, Sweden.<br /><searchLink fieldCode="AU" term="%22Mandula+H%22">Mandula H</searchLink>; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Zhao+Z%22">Zhao Z</searchLink>; Office of Pharmaceutical Quality (OPQ), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), Silver Spring, Maryland 20903-1058, United States.<br /><searchLink fieldCode="AU" term="%22Ju+TR%22">Ju TR</searchLink>; Analytical R&D, AbbVie Inc., 1 North Waukegan Road, North Chicago, Illinois 60064, United States.<br /><searchLink fieldCode="AU" term="%22Wagner+C%22">Wagner C</searchLink>; Global Drug Product Development, Global CMC Development, the Healthcare Business of Merck KGaA, Darmstadt 64293, Germany.<br /><searchLink fieldCode="AU" term="%22Arora+S%22">Arora S</searchLink>; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Wang+M%22">Wang M</searchLink>; Pharmaceutical Sciences and Clinical Supply, Merck & Co., Inc., Rahway, New Jersey 07065, United States.<br /><searchLink fieldCode="AU" term="%22Rullo+G%22">Rullo G</searchLink>; Regulatory CMC, AstraZeneca, 1 Medimmune Way, Gaithersburg, Maryland 20878, United States.<br /><searchLink fieldCode="AU" term="%22Mitra+A%22">Mitra A</searchLink>; Clinical Pharmacology, Kura Oncology Inc, Boston, Massachusetts 02210, United States.<br /><searchLink fieldCode="AU" term="%22Kollipara+S%22">Kollipara S</searchLink>; Biopharmaceutics Group, Global Clinical Management, Integrated Product Development Organization (IPDO), Dr. Reddy's Laboratories Ltd., Bachupally, Medchal Malkajgiri District, Hyderabad, 500 090 Telangana, India.<br /><searchLink fieldCode="AU" term="%22Chirumamilla+SK%22">Chirumamilla SK</searchLink>; Certara Predictive Technologies, Level 2-Acero, Simcyp Ltd, 1 Concourse Way, Sheffield S1 2BJ, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Polli+JE%22">Polli JE</searchLink>; School of Pharmacy, University of Maryland, Baltimore, Maryland 21201, United States.<br /><searchLink fieldCode="AU" term="%22Mackie+C%22">Mackie C</searchLink>; Janssen Pharmaceutica NV, Turnhoutseweg 30, 2340 Beerse, Belgium.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101197791%22">Molecular pharmaceutics</searchLink> [Mol Pharm] 2024 Nov 04; Vol. 21 (11), pp. 5353-5372. <i>Date of Electronic Publication: </i>2024 Sep 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, U.S. Gov't, P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101197791 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-8392 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215438384%22">15438384 </searchLink><i>NLM ISO Abbreviation: </i>Mol Pharm <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39348508
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acs.molpharmaceut.4c00758
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5353
    Titles:
      – TitleFull: PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Heimbach T
      – PersonEntity:
          Name:
            NameFull: Musuamba Tshinanu F
      – PersonEntity:
          Name:
            NameFull: Raines K
      – PersonEntity:
          Name:
            NameFull: Borges L
      – PersonEntity:
          Name:
            NameFull: Kijima S
      – PersonEntity:
          Name:
            NameFull: Malamatari M
      – PersonEntity:
          Name:
            NameFull: Moody R
      – PersonEntity:
          Name:
            NameFull: Veerasingham S
      – PersonEntity:
          Name:
            NameFull: Seo P
      – PersonEntity:
          Name:
            NameFull: Turner D
      – PersonEntity:
          Name:
            NameFull: Fang L
      – PersonEntity:
          Name:
            NameFull: Stillhart C
      – PersonEntity:
          Name:
            NameFull: Bransford P
      – PersonEntity:
          Name:
            NameFull: Ren X
      – PersonEntity:
          Name:
            NameFull: Patel N
      – PersonEntity:
          Name:
            NameFull: Sperry D
      – PersonEntity:
          Name:
            NameFull: Chen H
      – PersonEntity:
          Name:
            NameFull: Rostami-Hodjegan A
      – PersonEntity:
          Name:
            NameFull: Lukacova V
      – PersonEntity:
          Name:
            NameFull: Sun D
      – PersonEntity:
          Name:
            NameFull: Nguefack JF
      – PersonEntity:
          Name:
            NameFull: Carducci T
      – PersonEntity:
          Name:
            NameFull: Grimstein M
      – PersonEntity:
          Name:
            NameFull: Pepin X
      – PersonEntity:
          Name:
            NameFull: Jamei M
      – PersonEntity:
          Name:
            NameFull: Stamatopoulos K
      – PersonEntity:
          Name:
            NameFull: Li M
      – PersonEntity:
          Name:
            NameFull: Sanghavi M
      – PersonEntity:
          Name:
            NameFull: Tannergren C
      – PersonEntity:
          Name:
            NameFull: Mandula H
      – PersonEntity:
          Name:
            NameFull: Zhao Z
      – PersonEntity:
          Name:
            NameFull: Ju TR
      – PersonEntity:
          Name:
            NameFull: Wagner C
      – PersonEntity:
          Name:
            NameFull: Arora S
      – PersonEntity:
          Name:
            NameFull: Wang M
      – PersonEntity:
          Name:
            NameFull: Rullo G
      – PersonEntity:
          Name:
            NameFull: Mitra A
      – PersonEntity:
          Name:
            NameFull: Kollipara S
      – PersonEntity:
          Name:
            NameFull: Chirumamilla SK
      – PersonEntity:
          Name:
            NameFull: Polli JE
      – PersonEntity:
          Name:
            NameFull: Mackie C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 11
              Text: 2024 Nov 04
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1543-8392
          Numbering:
            – Type: volume
              Value: 21
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Molecular pharmaceutics
              Type: main
ResultId 1